Stock ownership · SEC 13F · Q4 2025

TERNS PHARMACEUTICALS INC

Institutional ownership of TERNS PHARMACEUTICALS INC (CUSIP 880881107) - who holds it, how concentrated it is, and what moved last quarter.

$1.5M
Reported value
2
Institutions
100%
Top-5 share

The verdict

2 institutions report $1.5M of TERNS PHARMACEUTICALS INC positions as of Q4 2025, with ownership heavily concentrated in a handful of holders.

2
institutions hold it
$1.5M
reported 13F value
100%
held by top 5

Based on long positions reported to the SEC as of Q4 2025; 13F omits shorts, options and non-US holdings.

How 13F ownership is computed · All tracked stocks · Concentration rankings

SEC Form 13F-HR ownership desk

CUSIP 880881107 · Q4 2025 $1M reported

VALUE-TRACE · HOLDERS-FOCUS · CONC-DOM · PHOTO-UNK · ACTIVITY-LIGHT · BOOK-MID

  • VALUE-TRACE $1.5M
  • HOLDERS-FOCUS 2 filers
  • CONC-DOM 100% top-5
  • PHOTO-UNK No peer
  • ACTIVITY-LIGHT 2 new
  • BOOK-MID 5Q history

Read with: Ownership concentration guide - TERNS PHARMACEUTICALS INC's top-five holders account for 100% of reported value — read concentration before treating any single filer as a signal.

Institutional ownership over time

The number of institutions reporting a TERNS PHARMACEUTICALS INC position has risen from 1 to 2 over the last 5 quarters of 13F filings.

0.511.522.5 Q4'24Q1'25Q2'25Q3'25Q4'25 2
Distinct 13F filers holding TERNS PHARMACEUTICALS INC, by quarter

Top Institutional Holders

# Institution Shares Value Share of reported
1 Seven Fleet Capital Management LP 36,894 $1.5M 100.0%
2 Bell Investment Advisors, Inc 12 $485 0.0%

Investment Discretion

SEC Form 13F requires each institutional filer to report whether it exercises sole or shared discretion over a position. Among TERNS PHARMACEUTICALS INC's reported holders for Q4 2025, by reported value:

Sole discretion (SOLE)
100.0%

Latest Quarter Activity · Q4 2025

Frequently Asked Questions

How many institutions hold TERNS PHARMACEUTICALS INC?
TERNS PHARMACEUTICALS INC is held by 2 institutional investors per the latest SEC Form 13F filings as of Q4 2025.
What is the total institutional value of TERNS PHARMACEUTICALS INC?
Institutions report $1.5M of TERNS PHARMACEUTICALS INC as of Q4 2025.
How concentrated is ownership of TERNS PHARMACEUTICALS INC?
The top five institutional holders account for 100% of the reported institutional value in TERNS PHARMACEUTICALS INC, making ownership heavily concentrated in a handful of holders.
Who is the largest institutional holder of TERNS PHARMACEUTICALS INC?
Seven Fleet Capital Management LP is the largest reported holder of TERNS PHARMACEUTICALS INC with $1.5M across 36,894 shares as of Q4 2025.

Source: U.S. Securities and Exchange Commission (SEC) - EDGAR Form 13F-HR institutional holdings filings · Q4 2025 13F-HR discloses long US-listed equity positions of managers with $100M+ qualifying assets, filed within 45 days of period end. Short positions and most derivatives are not disclosed.

PlainFundData is rendered directly from SEC EDGAR Form 13F-HR institutional holdings filings, no number is typed in by an editor. Holder lists, concentration, and reported value on this page are aggregated live from those 13F-HR extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-16.